Literature DB >> 15981111

Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma.

Carlo Palmieri, Cathryn Brock, Edward S Newlands.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981111     DOI: 10.1007/s11060-004-3577-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  4 in total

1.  Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Authors:  M Brada; K Hoang-Xuan; R Rampling; P Y Dietrich; L Y Dirix; D Macdonald; J J Heimans; B A Zonnenberg; J M Bravo-Marques; R Henriksson; R Stupp; N Yue; J Bruner; M Dugan; S Rao; S Zaknoen
Journal:  Ann Oncol       Date:  2001-02       Impact factor: 32.976

2.  Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.

Authors:  S W Hansen; J G Berthelsen; H von der Maase
Journal:  J Clin Oncol       Date:  1990-10       Impact factor: 44.544

3.  DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one.

Authors:  N W Gibson; J A Hickman; L C Erickson
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

4.  Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study.

Authors:  J Gaffan; L Holden; E S Newlands; D Short; S Fuller; R H J Begent; G J S Rustin; M J Seckl
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

  4 in total
  6 in total

1.  Effect of temozolomide on male gametes: an epigenetic risk to the offspring?

Authors:  I Berthaut; D Montjean; L Dessolle; K Morcel; F Deluen; C Poirot; A Bashamboo; K McElreavey; C Ravel
Journal:  J Assist Reprod Genet       Date:  2013-05-08       Impact factor: 3.412

2.  Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.

Authors:  R E Strowd; R Blackwood; M Brown; M Harmon; J Lovato; T Yalcinkaya; G Lesser
Journal:  J Oncol Pharm Pract       Date:  2013-01-04       Impact factor: 1.809

Review 3.  Medical management of brain tumors and the sequelae of treatment.

Authors:  David Schiff; Eudocia Q Lee; Lakshmi Nayak; Andrew D Norden; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2014-10-30       Impact factor: 12.300

4.  Two successful pregnancies following fertility preservation in a patient with anaplastic astrocytoma: a case report.

Authors:  Alexandra Peyser; Sara L Bristow; Avner Hershlag
Journal:  BMC Cancer       Date:  2018-05-09       Impact factor: 4.430

Review 5.  Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function.

Authors:  Virginia Zamponi; Anna La Salvia; Maria Grazia Tarsitano; Nevena Mikovic; Maria Rinzivillo; Francesco Panzuto; Elisa Giannetta; Antongiulio Faggiano; Rossella Mazzilli
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

6.  Fertility preservation in primary brain tumor patients.

Authors:  Jacqueline B Stone; Joanne F Kelvin; Lisa M DeAngelis
Journal:  Neurooncol Pract       Date:  2016-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.